-
公开(公告)号:US20240114903A1
公开(公告)日:2024-04-11
申请号:US18271769
申请日:2022-01-28
IPC分类号: A01N37/08 , A01N25/04 , A01N65/06 , A01N65/08 , A01N65/10 , A01N65/28 , A01N65/36 , A01N65/44 , A01N65/48 , A01P7/04 , A01P17/00
CPC分类号: A01N37/08 , A01N25/04 , A01N65/06 , A01N65/08 , A01N65/10 , A01N65/28 , A01N65/36 , A01N65/44 , A01N65/48 , A01P7/04 , A01P17/00
摘要: The subject matter described herein is directed to synergistic compositions comprising pyrethrum vapor and a second agent selected from the group consisting of an essential oil and a compound of Formula I. In other embodiments, topical synergistic compositions comprising pyrethrum and an essential oil are described. Additionally described are methods for repelling and controlling arthropods using the synergistic compositions.
-
公开(公告)号:US20240109938A1
公开(公告)日:2024-04-04
申请号:US18164942
申请日:2023-02-06
IPC分类号: C07K14/005 , C12N15/86 , C12N15/861
CPC分类号: C07K14/005 , C12N15/86 , C12N15/861 , A61K48/00 , C12N2750/14122 , C12N2750/14143
摘要: Provided herein are modified recombinant adeno-associated virus (rAAV) capsid proteins, such as modified rAAV1, rAAV5, and rAAV6 capsid proteins, rAAV particles comprising such capsid proteins, nucleic acid molecules encoding such capsid proteins, as well as compositions, kits and methods of use thereof.
-
公开(公告)号:US11945853B2
公开(公告)日:2024-04-02
申请号:US17839815
申请日:2022-06-14
发明人: Qiuhong Li , Mohan Raizada
IPC分类号: C07K14/575 , A61K35/00 , A61K35/74 , A61K35/741 , A61K35/747 , A61K45/06 , A61K48/00 , A61P3/00 , A61P3/10 , A61P9/12 , A61P27/02 , A61P29/00 , C07K7/14 , C07K14/195 , C07K14/28 , C07K14/47 , C07K19/00 , C12N1/00 , C12N9/48
CPC分类号: C07K14/575 , A61K35/74 , A61K35/741 , A61K35/747 , A61K45/06 , A61P3/00 , A61P3/10 , A61P9/12 , A61P27/02 , A61P29/00 , C07K7/14 , C07K14/195 , C07K14/28 , C07K14/47 , C07K19/00 , C12N1/00 , C12N9/485 , A61K2035/115 , A61K48/00 , C07K2319/02 , C07K2319/50 , C07K2319/60
摘要: Provided herein are polynucleic acids and expression vectors for the expression and secretion of angiotensin peptide fragments (e.g., angiotensin-(1-7)) in probiotic bacteria. Provided herein are also probiotic compositions that enable efficient, cost-effective and patient friendly oral therapeutics for treating diverse pathological conditions that involve the renin-angiotensin system (RAS), e.g., pulmonary hypertension, diabetes, diabetic complications, cardiovascular diseases, and ocular inflammatory and neurodegenerative diseases.
-
14.
公开(公告)号:US20240100174A1
公开(公告)日:2024-03-28
申请号:US18236078
申请日:2023-08-21
发明人: Matthew Eddy , Michael Harris , Amanda Pritzlaff
IPC分类号: A61K47/60 , C07K14/705
CPC分类号: A61K47/60 , C07K14/7056
摘要: Conjugation of polymers to proteins, including biomedically-relevant PEGylation, is a promising approach to address a central challenge of biologics and biotech: the lack of protein stability in demanding non-native environments. Application of conjugation is hindered by the lack of atomic level understanding of protein-polymerinteractions, preventing design of conjugates with predicted properties. An integrative structural and biophysical approach was used to address this challenge using a polymer-modified carbohydrate recognition domain of human galectin-3 (Gal3C), a lectin essential for cellular adhesion and potential biologic. Modification with PEG and other polymers dramatically increased Gal3C thermal stability and redirected its unfolding pathway through forming a stable intermediate. Distinct polymer properties which increased protein thermal stability were revealed. Structural details of Gal3C-polymer conjugates revealed by NMR pointed to the important role of polymer localization. Residues local to the site of conjugation were perturbed by polymer conjugation and these perturbations remained localized over a wide temperature range. For PEGylated conjugates, replacing key lysine residues within the PEG-perturbed region altered the protein-PEG interface and thermal unfolding behavior, providing mechanistic insight into rational design of conjugates that will expand the benefits of polymer conjugation.
-
公开(公告)号:US20240090136A1
公开(公告)日:2024-03-14
申请号:US18463988
申请日:2023-09-08
发明人: Navid ASADI-ZANJANI , John TRUE , Chengjie XI , Aslam KHAN
IPC分类号: H05K3/00
CPC分类号: H05K3/0005
摘要: Various embodiments of the present disclosure provide a framework for obfuscation of a printed circuit board (PCB). In one example, an embodiment provides for generating a plurality of connections interconnecting a plurality of components of the PCB using additive manufacturing, permuting, using a micro electro-mechanical systems (MEMS) device, a first set of connections interconnecting a first component with a second component in the PCB, integrating the MEMS device into the PCB such that the MEMS device covers a second set of connections from an x-ray probe, probing the PCB using x-ray simulation, and iteratively adjusting the permutation of the first set of connections and the integration of the MEMS device using a result of the x-ray simulation to reduce the detectability of the first and second connections based on the result of the x-ray simulation.
-
16.
公开(公告)号:US20240054745A1
公开(公告)日:2024-02-15
申请号:US18267490
申请日:2021-12-16
发明人: Perry B. Johnson
CPC分类号: G06T19/20 , G06T7/30 , G06T7/70 , A61N5/1049 , G16H40/63 , G06T2210/41 , G06T2219/2004 , G06T2207/10081 , G06T2207/30004 , A61B2090/364
摘要: According to at least one aspect, a series of images of a scene are obtained, such as by a head mounted display. The scene includes a medical device and a tracking device, and the series of images including at least the tracking device. Relative pose information indicative of a relative spatial relationship between the tracking device and the medical device is accessed, the 3D representation of the patient is registered with the medical device using the series of images of the scene and the relative pose information, and a mixed reality visualization of the 3D representation of the patient and the medical device generating, based on results of the registering. The mixed reality visualization can further include a visual indication indicative of an alignment of the patient with the 3D representation.
-
公开(公告)号:USD1013059S1
公开(公告)日:2024-01-30
申请号:US29813080
申请日:2021-10-26
设计人: Chenjie Zeng
摘要: FIG. 1 is a front orthogonal view of a set of modeling blocks showing the new design in a first configuration;
FIG. 2 is a front view of the invention illustrated in FIG. 1 in the first configuration;
FIG. 3 is a rear view of the invention illustrated in FIG. 1 in the first configuration;
FIG. 4 is a right side view of the invention illustrated in FIG. 1 in the first configuration;
FIG. 5 is a left side view of the invention illustrated in FIG. 1 in the first configuration;
FIG. 6 is a top view of the invention illustrated in FIG. 1 in the first configuration;
FIG. 7 is a bottom view of the invention illustrated in FIG. 1 in the first configuration;
FIG. 8 is another orthogonal view of the invention illustrated in FIG. 1 in the first configuration;
FIG. 9 is an orthogonal view of the set of modeling blocks illustrated in FIG. 1 in a second configuration;
FIG. 10 is a front view of the invention illustrated in FIG. 1 in the second configuration;
FIG. 11 is a rear view of the invention illustrated in FIG. 1 in the second configuration;
FIG. 12 is a right side view of the invention illustrated in FIG. 1 in the second configuration;
FIG. 13 is a left side view of the invention illustrated in FIG. 1 in the second configuration;
FIG. 14 is a top view of the invention illustrated in FIG. 1 in the second configuration;
FIG. 15 is a bottom view of the invention illustrated in FIG. 1 in the second configuration;
FIG. 16 is another orthogonal view of the invention illustrated in FIG. 1 in the second configuration;
FIG. 17 is an orthogonal view of the set of modeling blocks illustrated in FIG. 1 in a third configuration;
FIG. 18 is a front view of the invention illustrated in FIG. 1 in the third configuration;
FIG. 19 is a rear view of the invention illustrated in FIG. 1 in the third configuration;
FIG. 20 is a right side view of the invention illustrated in FIG. 1 in the third configuration;
FIG. 21 is a left side view of the invention illustrated in FIG. 1 in the third configuration;
FIG. 22 is a top view of the invention illustrated in FIG. 1 in the third configuration;
FIG. 23 is a bottom view of the invention illustrated in FIG. 1 in the third configuration;
FIG. 24 is another orthogonal view of the invention illustrated in FIG. 1 in the third configuration;
FIG. 25 is an orthogonal view of the set of modeling blocks illustrated in FIG. 1 in a fourth configuration;
FIG. 26 is a front view of the invention illustrated in FIG. 1 in the fourth configuration;
FIG. 27 is a rear view of the invention illustrated in FIG. 1 in the fourth configuration;
FIG. 28 is a right side view of the invention illustrated in FIG. 1 in the fourth configuration;
FIG. 29 is a left side view of the invention illustrated in FIG. 1 in the fourth configuration;
FIG. 30 is a top view of the invention illustrated in FIG. 1 in the fourth configuration;
FIG. 31 is a bottom view of the invention illustrated in FIG. 1 in the fourth configuration; and,
FIG. 32 is another orthogonal view of the invention illustrated in FIG. 1 in the fourth configuration.
The broken lines in the drawings depict environment, or portions, of the set of modeling blocks that form no part of the claimed design. The appearance of any portion of the article between the break lines forms no part of the claimed design. The surface shading in FIGS. 1-32 indicates a surface having a different color and/or texture from an unshaded surface.-
公开(公告)号:US11887686B2
公开(公告)日:2024-01-30
申请号:US17357265
申请日:2021-06-24
发明人: Yier Jin , Yichen Jiang , Xuan Zhang , Huifeng Zhu , Xiaolong Guo
IPC分类号: G06F21/57 , G11C11/406 , G11C11/4076 , G11C29/52 , G11C11/4096 , G11C7/24 , G11C11/4078 , G11C29/04 , G11C29/20
CPC分类号: G11C29/52 , G11C7/24 , G11C11/4076 , G11C11/4078 , G11C11/4096 , G11C11/40611 , G11C29/04 , G11C29/20
摘要: Embodiments provide for predicting rowhammer attack vulnerability of one or more memory cells of a direct random access memory (DRAM) chip, the DRAM chip including a plurality of memory cells. An example method, determines, for each memory cell of a subset of memory cells of the plurality of memory cells, a leakage time t, a resistance of intrinsic leakage RL based at least in part on the leakage time t, an activation time of an adjacent aggressor row to flip a bit in the memory cell, a resistance of coupling leaking RSW based at least in part on the activation time, and a toggling count. The method identifies, based at least in part on one or more of the RSW, RL, or toggling count, whether the direct random memory access (DRAM) chip is vulnerable to a rowhammer attack.
-
公开(公告)号:US20240024227A1
公开(公告)日:2024-01-25
申请号:US18028937
申请日:2021-09-28
CPC分类号: A61K9/0043 , A61K31/658 , A61P35/00 , A61P25/28 , A61K36/185 , A61K9/5176 , A61M15/08
摘要: Disclosed is a method and composition for using plant extracellular vesicles (EVs) as vectors for delivering therapeutic molecules to the CNS. We demonstrated that plant EVs are more efficient vectors than delivery with other methods. These vectors can used to treat diseases in the CNS, such as cancer, injuries like TBI, degeneration such as Alzheimer's and aging and cognitive disorders such as PTSD, depression and anxiety. New data using hemp derived EVs to treat cancers in the brain and to impact precursor cells in the brain and isolation of EVs are included. In addition, disclosed is an improvement on the efficacy of intra-nasal delivery and oral delivery when using EVs.
-
公开(公告)号:US11879144B2
公开(公告)日:2024-01-23
申请号:US18152329
申请日:2023-01-10
发明人: Yousong Ding , Ran Zuo
CPC分类号: C12P13/227 , C12N9/0006 , C12N9/0042 , C12N9/0075 , C12N15/62 , C12Y101/9901 , C12Y106/02004 , C12Y114/13039
摘要: The disclosure relates, in some aspects, to compositions and methods useful for production of nitrated aromatic molecules. The disclosure is based, in part, on whole cell systems expressing artificial fusion proteins comprising cytochrome P450 enzymes linked to reductase enzymes. In some aspects, the disclosure relates to methods of producing nitrated aromatic molecules in whole cell systems having artificial fusion proteins comprising cytochrome P450 enzymes linked to reductase enzymes.
-
-
-
-
-
-
-
-
-